NCT03668093

Brief Summary

randomized clinical study to evaluate 'caries management by risk assessment' Versus 'international caries classification and management system' Caries Risk Assessment Models Acquisition On Treatment Plan In Young Adult Population with null hypothesis that International Caries Classification and Management System (ICCMS™) will have the same clinical performance as Caries management by risk assessment (CAMBRA)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 8, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 12, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

March 4, 2020

Status Verified

March 1, 2020

Enrollment Period

1 year

First QC Date

September 8, 2018

Last Update Submit

March 3, 2020

Conditions

Keywords

caries preventioncaries management

Outcome Measures

Primary Outcomes (1)

  • new carious lesions

    Primary outcome :-New carious lesions Measuring device:- Visual-Tactile \& Digital radiograph "Digora" Measuring unit :- Scoring system (ordinal) (ICDASTM code 0) Sound surfaces Initial stage caries (ICDASTM codes 1 and 2) First or distinct visual changes in enamel seen as a carious opacity or visible discolouration Moderate stage caries (ICDASTM codes 3 and 4) A white or brown spot lesion with Localised enamel breakdown, without visible dentine exposure (ICDASTM code 3), or an Underlying dentine shadow (ICDASTM code 4) Extensive stage caries (ICDASTM codes 5 and 6) A distinct cavity in opaque or discoloured enamel with visible dentine (ICDASTM code 5 or 6).

    12 months

Study Arms (2)

ICCMS

EXPERIMENTAL

Intervention

Other: CAMBRA

CAMBRA

ACTIVE COMPARATOR

Comparator

Other: ICCM

Interventions

ICCMOTHER

comprehensive system for caries management

CAMBRA
CAMBRAOTHER

Caries risk assessment model

ICCMS

Eligibility Criteria

Age17 Years - 22 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • New patients
  • Able to give informed consent in Arabic
  • Unlikely to move from the area within 1y for work educational, or personal reasons (determined by residential history and questioning);
  • Willing to participate regardless of group assignment
  • Willing to comply with all study procedures and protocol
  • ≥16 permanent teeth

You may not qualify if:

  • Patient not willing to have dental radiographs taken
  • Patient with significant past or current medical conditions that might affect oral health or oral flora (i.e., diabetes, human immunodeficiency virus, heart conditions requiring antibiotic prophylaxis)
  • Patient with medication use that might affect the oral flora or salivary flow (e.g., antibiotic use in the past 3 months, drugs associated with dry mouth/xerostomia)
  • Patient with root caries at enrollment
  • Patient with periodontal disease requiring surgery, chemotherapeutic agents, or frequent prophylaxis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yomna

Cairo, Egypt

Location

MeSH Terms

Conditions

Dental Caries

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Study Officials

  • Yomna Khallaf, MD

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
demonstrator

Study Record Dates

First Submitted

September 8, 2018

First Posted

September 12, 2018

Study Start

November 1, 2018

Primary Completion

November 1, 2019

Study Completion

December 1, 2019

Last Updated

March 4, 2020

Record last verified: 2020-03

Locations